TY - JOUR
T1 - The addition of manual lymph drainage to compression therapy for breast cancer related lymphedema
T2 - A randomized controlled trial
AU - McNeely, Margaret L.
AU - Magee, David J.
AU - Lees, Alan W.
AU - Bagnall, Keith M.
AU - Haykowsky, Mark
AU - Hanson, John
N1 - Funding Information:
This research was supported in part by grants from the Cross Cancer Institute Clinical Trials Committee and the Canadian Breast Cancer Foundation: Alberta Chapter. We would like to acknowledge the assistance of Terry Kaasa, Janice Yurick, Colleen Lazoruk and Marilyn Sutherland, from the Rehabilitation Medicine Department of the Cross Cancer Institute, without
Funding Information:
The study was conducted at the Cross Cancer Institute in Edmonton, Canada. The study was approved by the Research Ethics Committee of the Alberta Cancer Board and the Health Research Ethics Board of the University of Alberta. Written informed consent was obtained from all subjects.
PY - 2004/7
Y1 - 2004/7
N2 - Purpose. The purpose of this investigation was to compare the reduction in arm lymphedema volume achieved from manual lymph drainage massage (MLD) in combination with multi-layered compression bandaging (CB) to that achieved by CB alone. Methods and materials. Fifty women with lymphedema (mean age of 59 years ±13 years) were randomly assigned to 4 weeks of combined MLD/CB or CB alone. The primary study endpoint was the reduction in arm lymphedema volume, which was determined by water displacement volumetry and measurement of circumference. Independent assessors, blinded to subject treatment assignment, performed the outcome measurements. Results. Arm lymphedema volume decreased significantly after 4 weeks irrespective of treatment assignment (p < 0.001). Individuals with mild lymphedema receiving combined MLD/CB had a significantly larger percentage reduction in volume compared to individuals with mild lymphedema receiving CB alone, and compared to individuals with moderate or severe lymphedema receiving either treatment. Conclusion. These findings indicate that CB, with or without MLD, is an effective intervention in reducing arm lymphedema volume. The findings suggest that CB on its own should be considered as a primary treatment option in reducing arm lymphedema volume. There may be an additional benefit from the application of MLD for women with mild lymphedema; however, this finding will need to be further examined in the research setting.
AB - Purpose. The purpose of this investigation was to compare the reduction in arm lymphedema volume achieved from manual lymph drainage massage (MLD) in combination with multi-layered compression bandaging (CB) to that achieved by CB alone. Methods and materials. Fifty women with lymphedema (mean age of 59 years ±13 years) were randomly assigned to 4 weeks of combined MLD/CB or CB alone. The primary study endpoint was the reduction in arm lymphedema volume, which was determined by water displacement volumetry and measurement of circumference. Independent assessors, blinded to subject treatment assignment, performed the outcome measurements. Results. Arm lymphedema volume decreased significantly after 4 weeks irrespective of treatment assignment (p < 0.001). Individuals with mild lymphedema receiving combined MLD/CB had a significantly larger percentage reduction in volume compared to individuals with mild lymphedema receiving CB alone, and compared to individuals with moderate or severe lymphedema receiving either treatment. Conclusion. These findings indicate that CB, with or without MLD, is an effective intervention in reducing arm lymphedema volume. The findings suggest that CB on its own should be considered as a primary treatment option in reducing arm lymphedema volume. There may be an additional benefit from the application of MLD for women with mild lymphedema; however, this finding will need to be further examined in the research setting.
KW - Breast cancer
KW - Compression bandaging
KW - Compression therapy
KW - Lymphedema
KW - Manual lymph drainage
KW - Physical therapy
UR - http://www.scopus.com/inward/record.url?scp=3342907074&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3342907074&partnerID=8YFLogxK
U2 - 10.1023/B:BREA.0000032978.67677.9f
DO - 10.1023/B:BREA.0000032978.67677.9f
M3 - Article
C2 - 15319562
AN - SCOPUS:3342907074
SN - 0167-6806
VL - 86
SP - 95
EP - 106
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 2
ER -